» Articles » PMID: 26784178

In Vitro and in Vivo Neuroprotective Effects of Walnut (Juglandis Semen) in Models of Parkinson's Disease

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2016 Jan 20
PMID 26784178
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Monoamine oxidase (MAO) catalyzes the oxidative deamination of monoamines including dopamine (DA). MAO expression is elevated in Parkinson's disease (PD). An increase in MAO activity is closely related to age, and this may induce neuronal degeneration in the brain due to oxidative stress. MAO (and particularly monoamine oxidase B (MAO-B)) participates in the generation of reactive oxygen species (ROS), such as hydrogen peroxide that are toxic to dopaminergic cells and their surroundings. Although the polyphenol-rich aqueous walnut extract (JSE; an extract of Juglandis Semen) has been shown to have various beneficial bioactivities, no study has been dedicated to see if JSE is capable to protect dopaminergic neurons against neurotoxic insults in models of PD. In the present study we investigated the neuroprotective potential of JSE against 1-methyl-4-phenylpyridinium (MPP⁺)- or 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicities in primary mesencephalic cells and in a mouse model of PD. Here we show that JSE treatment suppressed ROS and nitric oxide productions triggered by MPP⁺ in primary mesencephalic cells. JSE also inhibited depletion of striatal DA and its metabolites in vivo that resulted in significant improvement in PD-like movement impairment. Altogether our results indicate that JSE has neuroprotective effects in PD models and may have potential for the prevention or treatment of PD.

Citing Articles

Neuroprotective effects of walnut in nervous system disorders: A comprehensive review.

Rahbardar M, Hosseinzadeh H Iran J Basic Med Sci. 2024; 27(12):1492-1505.

PMID: 39539440 PMC: 11556768. DOI: 10.22038/ijbms.2024.79854.17302.


Functional foods and their impact on health.

Essa M, Bishir M, Bhat A, Chidambaram S, Al-Balushi B, Hamdan H J Food Sci Technol. 2023; 60(3):820-834.

PMID: 36908338 PMC: 9998796. DOI: 10.1007/s13197-021-05193-3.


Pharmacotherapeutic potential of walnut (Juglans spp.) in age-related neurological disorders.

Hosseini Adarmanabadi S, Gilavand H, Taherkhani A, Sadat Rafiei S, Shahrokhi M, Faaliat S IBRO Neurosci Rep. 2022; 14:1-20.

PMID: 36507190 PMC: 9727645. DOI: 10.1016/j.ibneur.2022.10.015.


Variations in Antioxidant Capacity, Oxidative Stability, and Physicochemical Quality Parameters of Walnut () Oil with Roasting and Accelerated Storage Conditions.

Elouafy Y, Lakhlifi El Idrissi Z, El Yadini A, Harhar H, Alshahrani M, Abdullah Al Awadh A Molecules. 2022; 27(22).

PMID: 36431794 PMC: 9696496. DOI: 10.3390/molecules27227693.


Multifunctional role of natural products for the treatment of Parkinson's disease: At a glance.

Rahman M, Wang X, Islam M, Akash S, Supti F, Mitu M Front Pharmacol. 2022; 13:976385.

PMID: 36299886 PMC: 9590378. DOI: 10.3389/fphar.2022.976385.


References
1.
Ju M, Kim H, Choi J, Ryu J, Hur J, Kim Y . Cassiae semen, a seed of Cassia obtusifolia, has neuroprotective effects in Parkinson's disease models. Food Chem Toxicol. 2010; 48(8-9):2037-44. DOI: 10.1016/j.fct.2010.05.002. View

2.
Holt A, SHARMAN D, Baker G, Palcic M . A continuous spectrophotometric assay for monoamine oxidase and related enzymes in tissue homogenates. Anal Biochem. 1997; 244(2):384-92. DOI: 10.1006/abio.1996.9911. View

3.
Marconi S, Zwingers T . Comparative efficacy of selegiline versus rasagiline in the treatment of early Parkinson's disease. Eur Rev Med Pharmacol Sci. 2014; 18(13):1879-82. View

4.
Matsuura K, Kabuto H, Makino H, Ogawa N . Pole test is a useful method for evaluating the mouse movement disorder caused by striatal dopamine depletion. J Neurosci Methods. 1997; 73(1):45-8. DOI: 10.1016/s0165-0270(96)02211-x. View

5.
Schapira A . Monoamine oxidase B inhibitors for the treatment of Parkinson's disease: a review of symptomatic and potential disease-modifying effects. CNS Drugs. 2011; 25(12):1061-71. DOI: 10.2165/11596310-000000000-00000. View